#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Nodal marginal zone B-cell lymphoma Leiomyosarcoma Allogenic stem cell transplantation Eosinophilic oesophagitis Hypochromic anaemia Inborn error of metabolism Intracranial germ cell tumour Chronic lymphocytic leukaemia recurrent Head and neck cancer Transplant rejection B-cell lymphoma recurrent Ependymoma Ocular myasthenia Malignant oligodendroglioma Retinitis pigmentosa More trials…

    Learn about Rare Diseases

    Proteus syndrome Phenylketonuria – Diagnostics Sarcoma – Basic Information Uterine leiomyosarcoma Combined immunodeficiency – Treatment Anaplastic thyroid cancer – Diagnostics Angiosarcoma recurrent – Basic Information SAPHO syndrome – Life with Disease Optic glioma – Trials in Disease Friedreich’s ataxia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tapentadol Hydrochloride SUMATRIPTAN Fluvastatin Sodium Oxygen Ph.eur. Tamibarotene Ads-011 Betula Alba Pollen Extract Elotuzumab Tramazoline Hydrochloride Ipn01194 Citalopram Hydrochloride Ecoo2 Acp-204 Tartrate Intestifix Darbepoetin Alfa Fluoxetine Meglumine Gadoterate Eletriptan Amikacin Sulfate Lutikizumab More therapies…

    Learn about Your Condition

    Appendicitis Double hit lymphoma Angelman's syndrome Non-Hodgkin's lymphoma Genital herpes simplex Juvenile idiopathic arthritis Peripheral artery angioplasty Vitiligo Herpes virus infection Skin bacterial infection Pyrexia Postprandial hypoglycaemia Procedural anxiety Urticaria Post procedural complication More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Erdosteine in Patients With COPD

    Recruiting

    3 1 1 1
    Italy

  • Semaglutide and Granisetron for Tolerability in Overweight Adults Without Diabetes

    Recruiting

    3 1 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • Granisetron
    • Semaglutide
    Estonia

  • EIK1001, Pembrolizumab, and Chemotherapy for Stage 4 Non-Small Cell Lung Cancer in Patients with Stage 4 Non-Small Cell Lung Cancer

    Recruiting

    2 1 1
    Investigated Drugs:
    • Pembrolizumab
    • Resiquimod Sulfate
    France Germany Greece Italy The Netherlands Romania +1

  • Duchenne Muscular Dystrophy in Patients with Gene Mutations Amenable to Exon 44 Skipping Treated with Delpacibart Zotadirsen

    Recruiting

    3 1
    Investigated Diseases:
    • Duchenne muscular dystrophy
    Belgium France Germany Italy The Netherlands Poland +1

  • Docetaxel and Apalutamide in Patients with Metastatic Hormone-Sensitive Prostate Cancer Who Did Not Have a Deep PSA Response After Initial Apalutamide Treatment

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Apalutamide
    • Docetaxel
    France Germany Italy Portugal Spain

  • INCA33890 With Standard Chemotherapy and Bevacizumab in First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Bevacizumab
    • Calcium Folinate
    • Fluorouracil
    Austria Belgium Denmark France Germany Italy +4
Previous Page
1 … 11 12 13 14 15 … 1,645
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!